Dihydrocaffeic Acid: A Multifaceted Compound from Natural Sources to Therapeutic Potential
Dihydrocaffeic acid is a monocarboxylic acid that is 3-phenylpropionic acid substituted by hydroxy groups at positions 3 and 4.
Mar 27，2025 Biochemical Engineering
2,4,6,8-Tetramethylcyclotetrasiloxane: An widely used crosslinker
2,4,6,8-Tetramethylcyclotetrasiloxane is a colorless, volatile liquid used primarily as an intermediate in the production of silicone polymers and resins.
Mar 27，2025 Organic Chemistry
2,2,6,6-Tetramethyl-3,5-heptanedione: conformational properties and metal chelates
2,2,6,6-Tetramethyl-3,5-heptanedioneis a stable, anhydrous reagent which undergoes O-additions and C-additions.
Mar 26，2025 Chemical Reagents
2-Cyclopenten-1-one: From Hsp70 Induction to Thermal Decomposition Studies
2-cyclopenten-1-one and its derivatives serve as valuable synthetic intermediates in organic synthesis as well as preferred structural motifs.
Mar 26，2025 Organic reagents
3,3-Dimethylbutyric acid: an intermediate used in chemical synthesis
3,3-dimethylbutyric acid is a dimethylbutyric acid in which both methyl substituents are at C3 and is used as an intermediate.
Mar 26，2025 Chemical Reagents
Immunosuppressant Ibrutinib:Indications, Class and Drug interactions
Ibrutinib is a first-in-class, potent, orally administered covalently-binding inhibitor of BTK, it may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.
Mar 25，2025 API
Tucatinib: Indications, Mechanism of Action and Side Effects
?Tucatinib is an oral small molecule tyrosine kinase inhibitor (TKI) sold under the trade name Tukysa.
Mar 25，2025 API
Uses of Eltrombopag Olamine in the Treatment of Thrombocytopenia
The use of eltrombopag has been permitted for ITP patients refractory to first-line drugs or splenectomy for the last 10 years. This article will introduce its mechanism, efficacy and safety.
Mar 25，2025 API
BCL2 inhibitor ABT-199
ABT-199(venetoclax, RG7601, GDC-0199) is a new selective small molecule inhibitor of BCL-2 that appears to spare platelets while achieving potent antitumor activity.
Mar 25，2025 API
Side effects of afatinib dimaleate
Afatinib dimaleate, the dimaleate form of afatinib, is an orally bioavailable anilinoquinazoline derivative that is an inhibitor of the epidermal growth factor receptor (ErbB; EGFR) family of receptor
Mar 25，2025 API